Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Jörg Weimer"'
Autor:
Jörg Weimer, Martje Hüttmann, Asiyan Nusilati, Svenja Andreas, Jona Röseler, Nils Tribian, Christoph Rogmans, Matthias Bernhard Stope, Edgar Dahl, Alexander Mustea, Elmar Stickeler, Nina Hedemann, Inken Flörkemeier, Katharina Tiemann, Svetlana Magadeeva, Astrid Dempfle, Norbert Arnold, Nicolai Maass, Dirk Bauerschlag
Publikováno v:
Journal of Cellular and Molecular Medicine. 27:379-391
Autor:
Nicolai Maass, Jörg Weimer, Dirk Bauerschlag, Theresa Link, Jan Dominik Kuhlmann, Wolfgang Lieb, Gerrit Hugendieck, Norbert Arnold, Christoph Rogmans, Inken Flörkemeier, Nina Hedemann, Anna-Christina Rambow
Publikováno v:
Cancers, Vol 13, Iss 5563, p 5563 (2021)
Cancers
Volume 13
Issue 21
Cancers
Volume 13
Issue 21
Ovarian cancer has the highest mortality rate among gynecological tumors. This is based on late diagnosis and the lack of early symptoms. To improve early detection, it is essential to find reliable biomarkers. The metalloprotease ADAM17 could be a p
Autor:
Dieter Kabelitz, Daniela Wesch, Matthias Peipp, Jörg Weimer, Dirk Bauerschlag, Lisa Janitschke, Vjola Sulaj, Norbert Arnold, Nina Hedemann, Daniel Gonnermann, Hans-Heinrich Oberg
Publikováno v:
Journal of Leukocyte Biology
Epithelial ovarian cancer displays the highest mortality of all gynecological tumors. A relapse of the disease even after successful surgical treatment is a significant problem. Resistance against the current platinum‐based chemotherapeutic standar
Autor:
Dirk Bauerschlag, Sarah Bringezu, Nadina Ortiz-Brüchle, Jolein Mijnes, Janina Tiedemann, Tobias Anzeneder, Vera Kloten, Peter A. Fasching, Ralf-Dieter Hilgers, Edgar Dahl, Hanna Schulz, Norbert Arnold, Julian Eschenbruch, Janina Gasthaus, Uwe Heindrichs, Benjamin Bruno, Jörg Weimer, Ruth Knüchel, Jennifer Freres, Sonja von Serenyi, Matthias Rübner, Nicolai Maass
Publikováno v:
Oncotarget
Introduction Mammography is the gold standard for early breast cancer detection, but shows important limitations. Blood-based approaches on basis of cell-free DNA (cfDNA) provide minimally invasive screening tools to characterize epigenetic alteratio
Autor:
Inken Flörkemeier, Jan Hendrik Schiepanski, Jan Dittrich, Julia Feuerborn, Christoph Rogmans, Nicolai Maass, Andreas Herz, Susanne Sebens, Jörg Weimer, Nina Hedemann, Astrid Dempfle, Dirk Bauerschlag, Sandra Krüger, Nils Tribian
Publikováno v:
Cancers, Vol 13, Iss 2039, p 2039 (2021)
Cancers
Volume 13
Issue 9
Cancers
Volume 13
Issue 9
Simple Summary Ovarian cancer (OvCa) treatment is still a challenge, mainly due to acquired resistance mechanisms during the course of chemotherapy. Here, we show the enhanced cytotoxicity of the combined treatment with the ADAM17 inhibitor GW280264X
Autor:
Ralf Weiskirchen, Jörg Weimer, Steffen K Meurer, Anja Kron, Barbara Seipel, Inga Vater, Norbert Arnold, Reiner Siebert, Lieming Xu, Scott L Friedman, Carsten Bergmann
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e75692 (2013)
The human hepatic cell line LX-2 has been described as tool to study mechanisms of hepatic fibrogenesis and the testing of antifibrotic compounds. It was originally generated by immortalisation with the Simian Vacuolating Virus 40 (SV40) transforming
Externí odkaz:
https://doaj.org/article/13fb714e156d4946b886667d8d892c0f
Autor:
Alexander Mustea, Matthias B. Stope, Norbert Arnold, Jörg Weimer, Dirk Bauerschlag, Rohwer F, Nicolai Maass, Felix Hilpert, Nina Hedemann
Publikováno v:
Current Opinion in Gynecology and Obstetrics. 1:15-23
Purpose: Seventy percent of all ovarian cancer (OvCa) diseases are diagnosed at an advanced stage due to poor screening methods. In general, the therapy consists of cyto-reductive surgery followed by first line platinum based chemo therapy, which fre
Autor:
Dirk Schmidt-Arras, Christoph Rogmans, Nina Hedemann, Susanne Sebens, Jörg Weimer, Ulrich Pecks, Nicolai Maass, Marion van Mackelenbergh, Hans-Heinrich Oberg, Daniela Wesch, Dirk Bauerschlag, Norbert Arnold, Manuel Reichert
Publikováno v:
Oncotarget
// Nina Hedemann 1 , Christoph Rogmans 1 , Susanne Sebens 2 , Daniela Wesch 3 , Manuel Reichert 4 , Dirk Schmidt-Arras 4 , Hans-Heinrich Oberg 3 , Ulrich Pecks 1 , Marion van Mackelenbergh 1 , Jorg Weimer 1 , Norbert Arnold 1 , Nicolai Maass 1 and Di
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie.
Autor:
Martin Burchardt, Madeleine Paditz, Matthias B. Stope, Dirk Bauerschlag, Alexander Mustea, Jörg Weimer, Dominique Koensgen
Publikováno v:
Archives of Gynecology and Obstetrics. 294:889-895
Endometrial cancer (EC) therapy is characterized by the heterogeneity of EC subtypes resulting in unclear clinical behavior as well as in unsatisfactory treatment options. The available biomarkers, such as cellular tumor antigen p53 (TP53), phosphati